Does EMDR Really Work? What Randomized Controlled Trials Have Found
If you want to know whether EMDR really works, randomized controlled trials are one of the most useful places to look.
These studies are designed to test treatments under controlled conditions. Instead of simply asking people whether they felt better after EMDR, researchers compare outcomes among people assigned to EMDR and people assigned to another treatment or comparison group.
EMDR has now been tested in randomized controlled trials for decades, particularly for post-traumatic stress disorder (PTSD).
The studies vary in size, population, treatment length, and what EMDR is compared against, but the overall pattern is clear: people receiving EMDR generally experience meaningful reductions in PTSD symptoms, and EMDR performs substantially better than waiting-list or usual-care conditions. When compared directly with other established psychological treatments, EMDR generally produces similar overall outcomes. (PubMed)
That does not mean every EMDR trial reaches exactly the same result. It means that the findings have been repeated often enough across controlled studies to form an important part of the evidence supporting EMDR.
What Is a Randomized Controlled Trial?
A randomized controlled trial, usually shortened to RCT, is a study in which participants are randomly assigned to different groups.
Imagine that researchers want to compare EMDR with another psychological treatment. Instead of allowing participants or researchers to decide who receives which treatment, participants are assigned randomly.
One group might receive EMDR. Another might receive a different established therapy.
In other studies, EMDR might be compared with usual care or a waiting-list condition.
Researchers then measure what happens to the participants over time.
Random assignment matters because people entering treatment are different from one another. Some begin with more severe symptoms. Some have experienced PTSD for longer. Some may have other psychological concerns alongside PTSD.
Randomization helps distribute these differences between groups rather than allowing one group to be deliberately filled with participants who might be more likely to improve.
It does not make a study perfect, but it makes the comparison more informative.
Why Are RCTs More Useful Than Simply Asking Whether People Improved?
Suppose 100 people receive EMDR and 70 report feeling substantially better afterward.
That would be useful information, but it would not answer every question.
Would some people have improved over the same period without EMDR? Would another established treatment have produced similar results? Could other factors have contributed to the improvement?
A controlled trial provides a comparison.
If people receiving EMDR improve substantially more than people on a waiting list or receiving usual care, that provides stronger evidence that the treatment itself is contributing to the difference.
Comparing EMDR with another effective treatment answers a harder question. Instead of asking whether EMDR is better than little or no active treatment, researchers are asking how it performs when the alternative is another treatment that may also work.
That distinction helps explain why different EMDR trials can report different-sized effects without necessarily contradicting one another.
What Have EMDR RCTs Found?
Randomized trials of EMDR have been conducted since the early years of the treatment and now cover several decades of research.
Many have focused on PTSD.
Researchers have measured outcomes such as:
overall PTSD symptom severity;
whether participants continue to meet diagnostic criteria for PTSD;
depression and anxiety symptoms;
treatment response and remission;
treatment completion or dropout;
and whether improvements remain after treatment.
Across the research, EMDR has repeatedly been associated with reductions in PTSD symptoms.
A recent systematic review specifically examined randomized controlled trials of EMDR for adults with PTSD published since the 2018 NICE guideline. Researchers identified 16 newer RCTs involving 1,031 participants and also incorporated trials from the earlier NICE evidence base into their analyses.
The review found that EMDR produced significantly greater improvement in PTSD symptoms than waiting-list or usual-care conditions. When EMDR was compared with trauma-focused cognitive behavioral therapy, however, there was no significant difference in treatment effect: both treatments significantly improved PTSD symptoms. (PubMed)
That is an important summary of what the RCT evidence actually tells us.
EMDR does not merely perform better than doing nothing. It has also held up in direct comparisons with established psychological treatments.
What Have Individual Trials Looked Like?
Individual randomized trials help show what these comparisons look like in practice.
One well-known study published in 2007 randomly assigned 88 adults with PTSD to EMDR, the antidepressant fluoxetine, or a pill placebo. Participants received eight weeks of treatment, and researchers assessed them after treatment and again six months later.
The study found sustained reductions in PTSD and depression symptoms following psychotherapy, with outcomes varying depending on participants' trauma histories.
The study is particularly useful because it did not simply compare EMDR with a waiting list—it compared a psychological treatment with medication and placebo and included a longer-term follow-up. (PubMed)
No individual trial, including this one, establishes the effectiveness of EMDR by itself. Its importance comes from being one part of a much larger collection of randomized research.
Earlier systematic work examining RCTs reached a similar broad conclusion. A review of 38 randomized controlled trials of psychological treatments for chronic PTSD found that EMDR and trauma-focused cognitive behavioral therapy both improved PTSD symptoms more than waiting-list or usual-care conditions.
The review found no evidence of a difference in efficacy between EMDR and trauma-focused CBT. (PubMed)
The repeated pattern across trials is more important than the result of any one study.
What Happens When EMDR Is Compared With a Waiting List?
Waiting-list comparisons answer a relatively straightforward question: do people receiving treatment improve more than people who are waiting for treatment?
For EMDR and PTSD, the answer across randomized research is generally yes.
A recent systematic review and meta-analysis focusing specifically on EMDR versus waiting list included 12 randomized trials with 690 participants.
The analysis found that EMDR reduced PTSD symptoms after treatment and may increase the likelihood that participants no longer meet criteria for a PTSD diagnosis. (PubMed)
The researchers also rated the certainty of some of these findings as low or very low because of limitations in the underlying studies.
That qualification is important, but so is keeping it in proportion.
It does not mean the trials found that EMDR was ineffective. It means researchers were more confident about the direction of the findings than about exactly how large some of the effects were.
This is one of the reasons it is useful to consider many different kinds of comparisons rather than relying only on trials against waiting lists.
What Happens When EMDR Is Compared With Another Effective Therapy?
This is a more demanding test.
If EMDR is compared with another established PTSD treatment, both groups may improve substantially. The question then becomes whether one produces better outcomes than the other.
Research has frequently compared EMDR with trauma-focused cognitive behavioral treatments.
A systematic review and meta-analysis of 11 randomized trials involving 424 adults with PTSD directly compared EMDR with cognitive behavioral therapy. Both were effective treatments.
The analysis found some outcomes favoring EMDR, but the authors also emphasized limitations in the number and quality of the original studies and cautioned against drawing overly strong conclusions about superiority. (PubMed)
More recent research has reinforced the broader picture.
An individual-participant-data meta-analysis identified 15 randomized trials comparing EMDR with other psychological treatments. Participant-level data from eight trials involving 346 people were available for the main analysis.
Researchers found no significant differences between EMDR and the other psychological treatments in PTSD symptom severity, treatment response, remission, or dropout. (PubMed)
Similarly, the more recent review of RCTs found EMDR significantly better than waiting-list or usual care but no significant treatment-effect difference between EMDR and trauma-focused CBT. (PubMed)
This does not weaken the case for EMDR.
Quite the opposite: performing similarly to another established treatment is evidence that EMDR itself is a serious treatment option.
Why Don't All RCTs Produce the Same Result?
If EMDR works, it might seem reasonable to expect every trial to reach exactly the same conclusion.
Real clinical research is rarely that uniform.
Trials differ in many ways.
One study might involve people who developed PTSD after a single traumatic event, while another includes people with different or repeated traumatic experiences. Studies may use different numbers of EMDR sessions, different outcome measures, and different follow-up periods.
The treatment being used for comparison also matters.
If EMDR is compared with a waiting list, researchers may see a relatively large difference between groups. If it is compared with another effective trauma-focused therapy, the difference between groups may be small because both groups are improving.
A 2026 review of RCTs published between 2000 and 2024 illustrates this pattern. EMDR was associated with a significant reduction in PTSD symptom severity overall, with larger effects against passive controls and smaller, comparable effects against active treatments. (PubMed)
So variation among trials is not automatically a sign that the evidence is contradictory. Often, the studies are simply asking different questions.
What Are the Limitations of EMDR RCTs?
Randomized controlled trials are valuable, but they are not automatically high-quality simply because they are randomized.
Some EMDR studies have relatively small samples. Researchers may also face challenges in keeping participants and treatment providers unaware of which treatment is being given—something that is much easier to do in a drug trial than in psychotherapy research.
Recent reviews have identified methodological concerns in a number of EMDR trials.
For example, the 2025 review of newer adult PTSD trials found that most studies had relatively small samples and that all but one were rated as having moderate or high risk of bias.
At the same time, the pooled findings still showed EMDR outperforming waiting-list or usual care and performing similarly to trauma-focused CBT. (PubMed)
The appropriate conclusion is therefore not that RCTs “prove” EMDR beyond question.
It is that multiple randomized trials conducted over decades have produced a consistent enough pattern to support EMDR as an effective treatment, particularly for PTSD, while better and larger trials can continue to make the estimates more precise.
Why Do Researchers Look Beyond Individual RCTs?
Even a well-designed RCT represents only one group of participants, one research setting, and one particular comparison.
That is why researchers use systematic reviews and meta-analyses to look across many randomized trials.
A large 2023 network meta-analysis, for example, examined 157 RCTs involving 11,565 adults with PTSD across several kinds of psychological treatment.
All of the therapies examined—including EMDR—were effective compared with control conditions, and the interventions did not differ significantly in overall efficacy. (PubMed)
A 2025 systematic review went another level higher and examined 55 published meta-analyses of randomized trials of psychological interventions for adult PTSD.
It found that psychological treatments consistently performed better than control conditions, with longer-term benefits beyond one month most consistently supported for trauma-focused CBT and EMDR.
The authors also found substantial differences in the quality of the meta-analyses themselves. (PubMed)
The next article in this series, What Do Meta-Analyses Say About EMDR?, looks specifically at why combining results from multiple studies can tell us more than relying on one trial.
Do RCTs Tell Us Whether EMDR Works for Everyone?
No.
Randomized trials tell us what happens on average across groups of participants.
Within any trial, people can have different outcomes. Some may experience large reductions in symptoms, others more modest changes, and some may show little improvement on the measure being studied.
That is true of psychological treatments generally.
RCTs therefore support statements such as “EMDR reduces PTSD symptoms on average” rather than promises about exactly what will happen for any particular person.
They also cannot be reduced to one universal “success rate.” Different trials define success differently—some examine symptom reduction, some treatment response, and some whether participants still meet diagnostic criteria for PTSD.
A later article in this series will examine those different definitions and why there is no single EMDR success-rate number.
Are RCTs Only Relevant to PTSD?
PTSD is the focus here because it has particularly strong and established EMDR research support and accounts for much of the randomized trial literature.
EMDR is also commonly used for anxiety, depression, grief, addictions, and other distressing experiences, and research has examined EMDR in a variety of these areas.
The key point is that RCT findings need to be understood in relation to what was actually studied. A trial involving adults with PTSD provides evidence about EMDR for that population and outcome. Researchers cannot simply assume that every result automatically applies to every other use of EMDR.
That is not unique to EMDR. It is how clinical research is interpreted generally.
What Can We Reasonably Conclude From the RCT Evidence?
Randomized controlled trials provide an important part of the answer to the question, “Does EMDR really work?”
Across decades of research, RCTs have repeatedly found reductions in PTSD symptoms among people receiving EMDR.
When EMDR is compared with waiting-list or usual-care conditions, people receiving EMDR generally show greater improvement. (PubMed)
When EMDR is compared with other established psychological treatments, particularly trauma-focused cognitive behavioral therapies, the differences are often small or not statistically significant because both treatments produce meaningful improvement. (PubMed)
Individual trials have limitations, and researchers continue to call for larger and methodologically stronger studies.
But randomized research does not depend on one famous EMDR trial or one unusually positive finding. It now represents a body of controlled studies conducted over many years.
The most reasonable conclusion from the RCT evidence is that EMDR works as a psychological treatment for PTSD and performs comparably overall with other established trauma-focused treatments.
Frequently Asked Questions
Have randomized controlled trials shown that EMDR works?
Yes. Numerous RCTs have found reductions in PTSD symptoms among people receiving EMDR. Recent research reviews find EMDR superior to waiting-list or usual-care conditions and broadly comparable with other established trauma-focused treatments. (PubMed)
What does “randomized” mean in an EMDR study?
It means participants are assigned to treatment or comparison groups using a random process rather than having researchers deliberately decide who receives each treatment. This helps make the groups more comparable and reduces certain forms of bias.
Is EMDR better than other PTSD treatments in randomized trials?
Not consistently. EMDR often performs substantially better than passive comparison conditions, but studies comparing it with other effective trauma-focused therapies frequently find similar overall outcomes. (PubMed)
Why are systematic reviews needed if RCTs are so useful?
One RCT can only tell researchers what happened in that particular study. Systematic reviews and meta-analyses combine information across many trials, helping researchers determine whether the overall pattern is consistent.
Does an RCT prove that EMDR will work for a particular person?
No. RCTs estimate average treatment effects across groups of participants. Individual outcomes vary, even when a treatment has strong overall evidence.
Conclusion
Randomized controlled trials are one of the strongest tools researchers have for determining whether a psychological treatment produces meaningful benefits.
For EMDR, decades of randomized research provide a clear overall picture.
EMDR consistently reduces PTSD symptoms compared with waiting-list or usual-care conditions. When it is compared with other established trauma-focused psychological treatments, the treatments generally produce similar overall outcomes rather than one consistently outperforming the other.
The individual trials are not perfect, and researchers continue to improve the quality and size of studies. But the RCT evidence is substantial enough that EMDR's effectiveness for PTSD does not rest on testimonials, theory, or a handful of uncontrolled observations.
It rests on repeated controlled comparisons—and those comparisons provide meaningful evidence that EMDR works.
